Subtotal Reportable Segments 447.1 17.5% 375.5 16.1%
Cost of Revenues Charges (c) (0.6) 0.0% (36.4) -1.6%
Restructuring and Other Costs, Net (d) (4.9) -0.2% (7.4) -0.3%
Amortization of Acquisition-related
Intangible Assets (151.2) -5.9% (139.3) -6.0%
GAAP Operating Income (a) $290.4 11.4% $192.4 8.2%
(a) "GAAP" (reported) results were determined in accordance with U.S.
generally accepted accounting principles (GAAP).
(b) Adjusted results are non-GAAP measures and exclude certain charges to
cost of revenues (see note (c) for details); amortization of
acquisition-related intangible assets; restructuring and other costs,
net (see note (d) for details); certain other gains or losses that are
either isolated or cannot be expected to occur again with any
regularity or predictability (see note (e) for details); the tax
consequences of the preceding items (see note (f) for details); and
results of discontinued operations.
(c) Reported results in 2008 include $0.3 for charges for the sale of
inventories revalued at the date of acquisition and $0.3 of
accelerated depreciation on manufacturing assets to be abandoned due
to facility consolidations. Reported results in 2007 include $36.4
primarily for charges for the sale of inventories revalued at the date
(d) Reported results in 2008 and 2007 include restructuring and other
costs, net, consisting principally of severance, abandoned facility
and other expenses of real estate consolidation.
(e) Reported results in 2008 include a $9.8 currency transaction gain
associated with an intercompany financing transaction.
(f) Reported provision for income taxes includes i) $49.6
|SOURCE Thermo Fisher Scientific Inc.|
Copyright©2008 PR Newswire.
All rights reserved